Compare Medpace Holdings Inc (MEDP) vs TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock (TTWO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medpace Holdings Inc vs TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock — how do they compare? Medpace Holdings Inc trades at $532.89 (market cap $15.08B), while TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock trades at $236.92 (market cap $44.37B). The key difference: TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock is far larger — about 2.9× Medpace Holdings Inc's market cap. Which is the better fit depends on your goals.
| MEDP | TTWO | |
|---|---|---|
Market Cap | $15.08B | $44.37B |
Sector | Technology | Media |
52-Week High | $620.59 | $262.29 |
52-Week Low | $308.88 | $189.69 |
Enterprise Value | $14.55B | $45.34B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MEDP trades at $527.93, down 1.82% today, with a bullish technical outlook supported by moving averages. The company demonstrates strong profitability with 17.19% net margins and 77.25% ROE, though valuation ratios appear elevated with a P/E of 33.83. Recent earnings have consistently beaten expectations, and cash flow is projected to improve significantly in 2026. However, the stock faces headwinds from ongoing class action lawsuits and mixed analyst sentiment with 73.69% hold ratings.
MEDP presents a mixed investment case with strong fundamental performance offset by legal overhangs and premium valuation. The company's consistent earnings beats and projected cash flow improvement support upside potential, but investors should weigh the legal risks and cautious analyst stance against the robust operational metrics.
Take-Two Interactive (TTWO) trades at $239.04, up 1.0% on the day, with a bullish technical outlook as the price approaches resistance near $240. The company reported three consecutive quarterly EPS beats but posted a net loss of -$4.48B in FY2025, with revenue growth to $5.63B. Investor focus remains on the upcoming Grand Theft Auto VI release, driving positive sentiment despite recent profitability challenges.
The stock offers significant upside to the consensus price target of $302.50, supported by strong analyst buy ratings (78.95%), but carries risks from high debt levels and negative margins. Near-term catalysts include Q2 2026 earnings on August 7, 2026, though execution on GTA VI and cost management are critical for sustained recovery.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →About TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock
Found in 1993, Take-Two consists of three wholly owned labels, Rockstar Games, 2K, and Zynga. The firm is one of the world's largest independent video game publishers on consoles, PCs, smartphones, and tablets. Take-Two's franchise portfolio is headlined by Grand Theft Auto (345 million units sold) and contains other well-known titles such as NBA 2K, Civilization, Borderlands, Bioshock, and Xcom. Zynga mobile titles include Farmville, Empires & Puzzles, and CSR Racing.
Read more on TTWO →
